These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 215522)
1. Heterogeneity of Epstein-Barr virus derived from P3HR-1 cells. zur Hausen H; Fresen KO IARC Sci Publ (1971); 1978; (20):391-6. PubMed ID: 215522 [TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of Epstein-Barr virus originating from P3HR-1 cells. I. Studies on EBNA induction. Fresen KO; Merkt B; Bornkamm GW; Hausen H Int J Cancer; 1977 Mar; 19(3):317-23. PubMed ID: 191406 [TBL] [Abstract][Full Text] [Related]
3. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus. Fresen KO; zur Hausen H Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313 [TBL] [Abstract][Full Text] [Related]
4. Effects of DNA synthesis inhibitors on early antigen expression following primary infection or superinfection by Epstein-Barr virus. Lidin BI; Lamon EW Arch Virol; 1983; 77(1):13-25. PubMed ID: 6312934 [TBL] [Abstract][Full Text] [Related]
5. Establishment of EBNA-expressing cell lines by infection of Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with different EBV strains. Fresen KO; Hausen H Int J Cancer; 1976 Feb; 17(2):161-6. PubMed ID: 175026 [TBL] [Abstract][Full Text] [Related]
8. An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection. Klein G; Giovanella B; Westman A; Stehlin JS; Mumford D Intervirology; 1975; 5(6):319-34. PubMed ID: 181343 [TBL] [Abstract][Full Text] [Related]
9. Hybridization of a myeloid leukemia-derived human cell line (K562) with a human Burkitt's lymphoma line (P3HR-1). Klein G; Zeuthen J; Eriksson I; Terasaki P; Bernoco M; Rosén A; Masucci G; Povey S; Ber R J Natl Cancer Inst; 1980 Apr; 64(4):725-38. PubMed ID: 6245297 [TBL] [Abstract][Full Text] [Related]
10. An EBNA-negative, EBV-genome-positive human lymphoblast cell line in which superinfecting EBV DNA is not maintained. Reisman D; Sugden B Virology; 1984 Aug; 137(1):113-26. PubMed ID: 6089410 [TBL] [Abstract][Full Text] [Related]
11. Relationship between Epstein-Barr virus nuclear antigen and DNA genome number in superinfected and induced lymphoblastoid cell lines. Boguszaková L; Hirsch I; Brichácek B; Vonka V J Gen Virol; 1983 Apr; 64 (Pt 4)():887-94. PubMed ID: 6300308 [TBL] [Abstract][Full Text] [Related]
12. Primary EBV infection of human umbilical cord lymphocytes and EBV genome-negative lymphoblastoid cell lines (BJAB and Ramos). Takimoto T; Sato H; Ogura H Auris Nasus Larynx; 1986; 13(3):199-205. PubMed ID: 3036055 [TBL] [Abstract][Full Text] [Related]
13. Molecular size variation of EBNA is determined by the EB viral genome. Gergely L; Sternås L; Dillner J; Klein G Intervirology; 1984; 22(2):85-96. PubMed ID: 6090339 [TBL] [Abstract][Full Text] [Related]
14. Relationship between the amounts of EBV-DNA and EBNA per cell, clonability and tumorigenicity in two ebv-negative lymphoma lines and their EBV-converted sublines. Ernberg I; Klein G; Giovanella BC; Stehlin J; McCormick KJ; Andersson-Anvret M; Aman P; Killander D Int J Cancer; 1983 Feb; 31(2):163-9. PubMed ID: 6298125 [TBL] [Abstract][Full Text] [Related]
15. Characterization of a second Epstein-Barr virus-determined nuclear antigen associated with the BamHI WYH region of EBV DNA. Dillner J; Kallin B; Ehlin-Henriksson B; Timar L; Klein G Int J Cancer; 1985 Mar; 35(3):359-66. PubMed ID: 2982749 [TBL] [Abstract][Full Text] [Related]
16. Studies on the association of the Epstein-Barr virus genome with chromosomes in human (Burkitt)/mouse hybrid cells. Glaser R; Croce C; Nonoyama M IARC Sci Publ (1971); 1978; (24 Pt 1):565-70. PubMed ID: 221361 [TBL] [Abstract][Full Text] [Related]
17. Analysis of epstein-Barr virus (EBV) of P3HR-1: isolation of EBV with EBNA induction ability in human cord lymphocytes and without EA induction ability in Raji cells. Yano S; Tanaka A; Takada K; Fujiwara S; Osato T; Nonoyama M Virology; 1982 Jun; 119(2):392-8. PubMed ID: 6281981 [No Abstract] [Full Text] [Related]
18. Blocking of acid-fixed nuclear binding of Epstein-Barr virus nuclear antigen (EBNA) by different DNA species. Hirsch I; Kuchlerová L; Brichácek B; Suchánková A; Vonka V J Gen Virol; 1979 Sep; 44(3):849-52. PubMed ID: 231093 [TBL] [Abstract][Full Text] [Related]
19. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains. Klein G; Ehlin-Henriksson B; Schlossman SF J Immunol; 1983 Apr; 130(4):1985-9. PubMed ID: 6300235 [TBL] [Abstract][Full Text] [Related]
20. The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization. Knutson JC J Virol; 1990 Jun; 64(6):2530-6. PubMed ID: 2159528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]